Literature DB >> 21684852

Potential strategies for an HIV infection cure.

Alain Lafeuillade1.   

Abstract

Despite long-term viral suppression with antiretroviral therapy (ART), HIV persists in reservoirs and sanctuary sites. Lifelong therapy is therefore necessary, leading to problems of compliance, toxicity, and cost. Over the last few years, important advances have been made in our understanding of the composition and the maintenance mechanisms of the HIV reservoir. Although complete viral eradication is currently out of reach, a growing number of scientists think that a "functional" cure is achievable. This situation would combine no disease progression, no virus transmission, and a life expectancy close to uninfected individuals in the absence of ART. At acute HIV infection, ART increases the frequency of sustained viremia control after its discontinuation, compared with the natural history of untreated disease. For patients at the chronic stage of HIV infection, ART alone is insufficient to clear viral reservoirs and new molecules intended to purge this reservoir or gene therapy approaches are warranted. This search for a cure needs innovation, audaciousness, and coordination. It also needs political, institutional, and private commitments for funding, which by now are severely lacking.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21684852     DOI: 10.1310/hct1203-121

Source DB:  PubMed          Journal:  HIV Clin Trials        ISSN: 1528-4336


  5 in total

1.  Currently available medications in resource-rich settings may not be sufficient for lifelong treatment of HIV.

Authors:  James Jansson; David P Wilson; Andrew Carr; Kathy Petoumenos; Mark A Boyd
Journal:  AIDS       Date:  2013-05-15       Impact factor: 4.177

Review 2.  Eliminating the HIV reservoir.

Authors:  Alain Lafeuillade
Journal:  Curr HIV/AIDS Rep       Date:  2012-06       Impact factor: 5.071

3.  Synthetic consensus HIV-1 DNA induces potent cellular immune responses and synthesis of granzyme B, perforin in HIV infected individuals.

Authors:  Matthew P Morrow; Pablo Tebas; Jian Yan; Lorenzo Ramirez; Anna Slager; Kim Kraynyak; Malissa Diehl; Divya Shah; Amir Khan; Jessica Lee; Jean Boyer; J Joseph Kim; Niranjan Y Sardesai; David B Weiner; Mark L Bagarazzi
Journal:  Mol Ther       Date:  2014-12-22       Impact factor: 11.454

Review 4.  Genetically modified hematopoietic stem cell transplantation for HIV-1-infected patients: can we achieve a cure?

Authors:  Patrick Younan; John Kowalski; Hans-Peter Kiem
Journal:  Mol Ther       Date:  2013-11-13       Impact factor: 11.454

5.  Development of hematopoietic stem cell based gene therapy for HIV-1 infection: considerations for proof of concept studies and translation to standard medical practice.

Authors:  David L DiGiusto; Rodica Stan; Amrita Krishnan; Haitang Li; John J Rossi; John A Zaia
Journal:  Viruses       Date:  2013-11-22       Impact factor: 5.048

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.